You just read:

Gilead Receives Approval in Canada for VEMLIDY™ (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

News provided by

Gilead Sciences, Inc.

Jun 19, 2017, 05:59 ET